Equity Profile

LQDA

Liquidia Corporation

Health CarePharmaceuticals$5.5B

Aug12Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Liquidia Corporation is a pharmaceutical company focused on developing innovative treatments for patients with serious diseases. Operating in the health care sector, it aims to improve patient outcomes through its advanced drug delivery technologies.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well Liquidia is managing its costs and generating revenue.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and validate its product offerings.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

LQDA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+21.08%

Avg Stock Reaction

+4.49%

Last Quarter Recap

In Q1-2026, Liquidia reported an EPS of $0.52, significantly beating expectations of $0.34, resulting in a 25.60% increase in stock price the next day. However, revenue figures were not disclosed, leaving some uncertainty.

Management Promises & Guidance

Continue to focus on innovative drug delivery technologies.
Aim for sustained profitability and growth in upcoming quarters.
Enhance communication regarding product pipeline developments.

Expectations

Wall Street Expectations

Overall, expectations are mixed as Liquidia has shown strong earnings surprises in recent quarters but lacks detailed revenue guidance. Investors are keen to see if the positive trend continues.

Bull Case

If Liquidia can replicate its previous earnings surprises, it may lead to significant stock price appreciation and increased investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a crucial indicator of profitability and will directly influence investor sentiment and stock performance.

What updates can be provided on revenue growth and product pipeline?

Clear guidance on revenue and product developments will help investors gauge the company's future prospects and market positioning.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Liquidia's ability to sustain its earnings momentum, particularly given the recent strong EPS surprises.

Supporting Evidence

Recent EPS surprises indicate strong operational performance that may not be fully reflected in current expectations.

The options market is pricing a larger move than historical averages suggest, indicating potential for significant volatility.

Insider selling may indicate confidence in the company's future performance despite the recent stock price increase.

Key Risk

If EPS comes in below $0.30, it could undermine the positive narrative built around recent earnings surprises.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating Liquidia's ability to maintain its recent earnings momentum and provide clear guidance for future growth.

Bull Confirmed If

An EPS of $0.60 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $0.30 would confirm the bear case and raise concerns about the company's profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±29.39%

Historical Avg

±6.48%

Pricing rich

The options market is pricing in a significant potential move around the earnings announcement, indicating heightened uncertainty or expectation.

Options are pricing a 29.39% move, while the stock has averaged only 6.48% over the last 8 quarters — setup is rich.

Detail

ATM IV

0.9%

30d HV

78.5%

Calls (67K)P/C Ratio: 0.18Puts (58K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

This setup has occurred 30 times across Health Care in the last 2 years. 14 of 29 faded and 15 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 4.9%, with a raw directional average of +1.8% (modestly positive historical bias).

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$20.7M

520,692 sh

8 insiders

Net

$20.7M

Net selling

Most Active Insiders· 21 open-market trades

CFO and COOKaseta Michael
$12.8M
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Liquidia beats expectations, history suggests a stock price increase of around 6.54%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further clarity from management.

Miss

A miss could lead to a decline in stock price, with history suggesting an average drop of 2.44%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any commentary on the product pipeline and expected launches.
2Details on cost management strategies and their impact on profitability.
3Insights into market demand for Liquidia's products.
4Updates on regulatory approvals or challenges.
5Management's outlook on future revenue growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug10

BWBMO

Babcock & Wilcox Enterprises, Inc.

PreviewView

Aug10

ROIVBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well Liquidia is managing its costs and generating revenue.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and validate its product offerings.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

LQDA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+21.08%

Avg Stock Reaction

+4.49%

Last Quarter Recap

Management Promises & Guidance

Continue to focus on innovative drug delivery technologies.
Aim for sustained profitability and growth in upcoming quarters.
Enhance communication regarding product pipeline developments.

Expectations

Wall Street Expectations

Overall, expectations are mixed as Liquidia has shown strong earnings surprises in recent quarters but lacks detailed revenue guidance. Investors are keen to see if the positive trend continues.

Bull Case

If Liquidia can replicate its previous earnings surprises, it may lead to significant stock price appreciation and increased investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a crucial indicator of profitability and will directly influence investor sentiment and stock performance.

What updates can be provided on revenue growth and product pipeline?

Clear guidance on revenue and product developments will help investors gauge the company's future prospects and market positioning.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Liquidia's ability to sustain its earnings momentum, particularly given the recent strong EPS surprises.

Supporting Evidence

Recent EPS surprises indicate strong operational performance that may not be fully reflected in current expectations.

The options market is pricing a larger move than historical averages suggest, indicating potential for significant volatility.

Insider selling may indicate confidence in the company's future performance despite the recent stock price increase.

Key Risk

If EPS comes in below $0.30, it could undermine the positive narrative built around recent earnings surprises.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating Liquidia's ability to maintain its recent earnings momentum and provide clear guidance for future growth.

Bull Confirmed If

An EPS of $0.60 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $0.30 would confirm the bear case and raise concerns about the company's profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±29.39%

Historical Avg

±6.48%

Pricing rich

The options market is pricing in a significant potential move around the earnings announcement, indicating heightened uncertainty or expectation.

Options are pricing a 29.39% move, while the stock has averaged only 6.48% over the last 8 quarters — setup is rich.

Detail

ATM IV

0.9%

30d HV

78.5%

Calls (67K)P/C Ratio: 0.18Puts (58K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$20.7M

520,692 sh

8 insiders

Net

$20.7M

Net selling

Most Active Insiders· 21 open-market trades

CFO and COOKaseta Michael
$12.8M
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Liquidia beats expectations, history suggests a stock price increase of around 6.54%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further clarity from management.

Miss

A miss could lead to a decline in stock price, with history suggesting an average drop of 2.44%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any commentary on the product pipeline and expected launches.
2Details on cost management strategies and their impact on profitability.
3Insights into market demand for Liquidia's products.
4Updates on regulatory approvals or challenges.
5Management's outlook on future revenue growth.